These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

617 related items for PubMed ID: 9794372

  • 1. Thymic positive selection and peripheral activation of islet antigen-specific T cells: separation of two diabetogenic steps by an I-A(g7) class II MHC beta-chain mutant.
    Kanagawa O, Vaupel BA, Xu G, Unanue ER, Katz JD.
    J Immunol; 1998 Nov 01; 161(9):4489-92. PubMed ID: 9794372
    [Abstract] [Full Text] [Related]

  • 2. Autoantigen-independent deletion of diabetogenic CD4+ thymocytes by protective MHC class II molecules.
    Schmidt D, Amrani A, Verdaguer J, Bou S, Santamaria P.
    J Immunol; 1999 Apr 15; 162(8):4627-36. PubMed ID: 10202002
    [Abstract] [Full Text] [Related]

  • 3. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
    Noorchashm H, Lieu YK, Noorchashm N, Rostami SY, Greeley SA, Schlachterman A, Song HK, Noto LE, Jevnikar AM, Barker CF, Naji A.
    J Immunol; 1999 Jul 15; 163(2):743-50. PubMed ID: 10395666
    [Abstract] [Full Text] [Related]

  • 4. beta cell-specific CD4+ T cell clonotypes in peripheral blood and the pancreatic islets are distinct.
    Li L, He Q, Garland A, Yi Z, Aybar LT, Kepler TB, Frelinger JA, Wang B, Tisch R.
    J Immunol; 2009 Dec 01; 183(11):7585-91. PubMed ID: 19917704
    [Abstract] [Full Text] [Related]

  • 5. Selection of aberrant class II restricted CD8+ T cells in NOD mice expressing a glutamic acid decarboxylase (GAD)65-specific T cell receptor transgene.
    Ranheim EA, Tarbell KV, Krogsgaard M, Mallet-Designe V, Teyton L, McDevitt HO, Weissman IL.
    Autoimmunity; 2004 Dec 01; 37(8):555-67. PubMed ID: 15763918
    [Abstract] [Full Text] [Related]

  • 6. Acceleration of spontaneous diabetes in TCR-beta-transgenic nonobese diabetic mice by beta-cell cytotoxic CD8+ T cells expressing identical endogenous TCR-alpha chains.
    Verdaguer J, Yoon JW, Anderson B, Averill N, Utsugi T, Park BJ, Santamaria P.
    J Immunol; 1996 Nov 15; 157(10):4726-35. PubMed ID: 8906855
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of clonal deletion vs. anergy of self-reactive CD4 T-cells for the prevention and reversal of autoimmune diabetes.
    Preda-Pais A, Stan AC, Casares S, Bona C, Brumeanu TD.
    J Autoimmun; 2005 Aug 15; 25(1):21-32. PubMed ID: 16005609
    [Abstract] [Full Text] [Related]

  • 8. T-splenocytes from non-obese diabetic mice binding to xenogeneic pancreatic beta-cells in vitro. Implication of the alpha/beta T-cell receptor and of major histocompatibility complex class II molecules from target cells.
    Martignat L, Feve B, Ouary M, Pogu S, Charbonnel B, Saï P.
    J Autoimmun; 1993 Dec 15; 6(6):753-69. PubMed ID: 8155255
    [Abstract] [Full Text] [Related]

  • 9. Pathological changes in the islet milieu precede infiltration of islets and destruction of beta-cells by autoreactive lymphocytes in a transgenic model of virus-induced IDDM.
    von Herrath M, Holz A.
    J Autoimmun; 1997 Jun 15; 10(3):231-8. PubMed ID: 9218748
    [Abstract] [Full Text] [Related]

  • 10. Selective development of CD4+ T cells in transgenic mice expressing a class II MHC-restricted antigen receptor.
    Kaye J, Hsu ML, Sauron ME, Jameson SC, Gascoigne NR, Hedrick SM.
    Nature; 1989 Oct 26; 341(6244):746-9. PubMed ID: 2571940
    [Abstract] [Full Text] [Related]

  • 11. Replacement of N-glycosylation sites on the MHC class II E alpha chain. Effect on thymic selection and peripheral T cell activation.
    Ishikawa S, Kowal C, Cole B, Thomson C, Diamond B.
    J Immunol; 1995 May 15; 154(10):5023-9. PubMed ID: 7730609
    [Abstract] [Full Text] [Related]

  • 12. The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders.
    Carrasco-Marin E, Shimizu J, Kanagawa O, Unanue ER.
    J Immunol; 1996 Jan 15; 156(2):450-8. PubMed ID: 8543793
    [Abstract] [Full Text] [Related]

  • 13. Induction of central T cell tolerance: recombinant antibodies deliver peptides for deletion of antigen-specific (CD4+)8+ thymocytes.
    Schjetne KW, Thommesen JE, Fredriksen AB, Lunde E, Sandlie I, Bogen B.
    Eur J Immunol; 2005 Nov 15; 35(11):3142-52. PubMed ID: 16184515
    [Abstract] [Full Text] [Related]

  • 14. CD8(+) T cells specific for beta cells encounter their cognate antigens in the islets of NOD mice.
    Pang S, Zhang L, Wang H, Yi Z, Li L, Gao L, Zhao J, Tisch R, Katz JD, Wang B.
    Eur J Immunol; 2009 Oct 15; 39(10):2716-24. PubMed ID: 19658094
    [Abstract] [Full Text] [Related]

  • 15. Limiting TCR expression leads to quantitative but not qualitative changes in thymic selection.
    Dave VP, Allman D, Wiest DL, Kappes DJ.
    J Immunol; 1999 May 15; 162(10):5764-74. PubMed ID: 10229809
    [Abstract] [Full Text] [Related]

  • 16. A peptide binding motif for I-Eg7, the MHC class II molecule that protects E alpha-transgenic nonobese diabetic mice from autoimmune diabetes.
    Gregori S, Trembleau S, Penna G, Gallazzi F, Hammer J, Papadopoulos GK, Adorini L.
    J Immunol; 1999 Jun 01; 162(11):6630-40. PubMed ID: 10352280
    [Abstract] [Full Text] [Related]

  • 17. Unopposed positive selection and autoreactivity in mice expressing class II MHC only on thymic cortex.
    Laufer TM, DeKoning J, Markowitz JS, Lo D, Glimcher LH.
    Nature; 1996 Sep 05; 383(6595):81-5. PubMed ID: 8779719
    [Abstract] [Full Text] [Related]

  • 18. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
    Gallichan WS, Balasa B, Davies JD, Sarvetnick N.
    J Immunol; 1999 Aug 01; 163(3):1696-703. PubMed ID: 10415077
    [Abstract] [Full Text] [Related]

  • 19. Pancreatic infiltration but not diabetes occurs in the relative absence of MHC class II-restricted CD4 T cells: studies using NOD/CIITA-deficient mice.
    Mora C, Wong FS, Chang CH, Flavell RA.
    J Immunol; 1999 Apr 15; 162(8):4576-88. PubMed ID: 10201997
    [Abstract] [Full Text] [Related]

  • 20. Differences in adhesion markers, activation markers, and TcR in islet infiltrating vs. peripheral lymphocytes in the NOD mouse.
    Goldrath AW, Barber L, Chen KE, Alters SE.
    J Autoimmun; 1995 Apr 15; 8(2):209-20. PubMed ID: 7612149
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.